(Q43290047)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19690151%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

title

Administration of miltefosine and meglumine antimoniate in healthy dogs: clinicopathological evaluation of the impact on the kidneys (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19690151%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

main subject

meglumine antimoniate

1 reference

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19690151%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

author name string

Paolo Bianciardi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19690151%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Claudio Brovida

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19690151%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Luca Aresu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19690151%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Laura Cavicchioli

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19690151%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Claudia Vischer

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19690151%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Lucie Giroud

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19690151%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Massimo Castagnaro

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19690151%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

language of work or name

English

0 references

publication date

18 August 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19690151%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

published in

Toxicologic Pathology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19690151%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

volume

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19690151%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19690151%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

page(s)

770-775

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19690151%20AND%20SRC:MED&resulttype=core&format=json

Canine leishmaniosis - new concepts and insights on an expanding zoonosis: part one.

5 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0192623309344088

Chemotherapy of canine leishmaniosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623309344088

Miltefosine to treat leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623309344088

A retrospective clinical study of canine leishmaniasis in 150 dogs naturally infected by Leishmania infantum

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623309344088

Histopathologic patterns of nephropathy in naturally acquired canine visceral leishmaniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623309344088

Practical guide for the treatment of leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623309344088

Alkylphosphocholines: a new class of membrane-active anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623309344088

Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623309344088

Comparative study on the short term efficacy and adverse effects of miltefosine and meglumine antimoniate in dogs with natural leishmaniosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623309344088

Canine leishmaniosis--new concepts and insights on an expanding zoonosis: part two.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623309344088

Pathological changes in kidneys of dogs with natural Leishmania infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623309344088

Treatment of canine Old World visceral leishmaniasis: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623309344088

Development status of miltefosine as first oral drug in visceral and cutaneous leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623309344088

Trial of oral miltefosine for visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623309344088

Possible mechanism of miltefosine-mediated death of Leishmania donovani

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623309344088

Glomerular lesions in dogs infected with Leishmania organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623309344088